MENU THE IMPORTANCE OF EVIDENCE-BASED MEDICINE IN POINT-OF-CARE TESTING AFRICAN FIRST LADIES MOBILIZE TO END TRANSMISSION OF MOTHER-TO-CHILD HIV AND SYPHILIS CALL FOR ACTION IN ACUTE HEART FAILURE: “TIME IS LIFE!” ALLAYING EMPLOYEES' CONCERNS ABOUT WORKPLACE DRUG TESTING ANTIMICROBIAL RESISTANCE: GETTING STRAIGHT TO THE POINT! ABOUT RAPID CRP TESTING IN PRIMARY CARE OVERCOMING THE SCREENING CHALLENGES OF NEW PSYCHOACTIVE SUBSTANCES COMPREHENSIVE DIABETES PATIENT CARE PROGRAM YIELDS MEASUREABLE RESULTS FIGHTING THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE ZIKA VIRUS: A GROWING PUBLIC HEALTH THREAT REFLECTING ON PROGRESS IN TOTAL ANALYTICAL ERROR REDUCTION IN DIAGNOSTIC TESTS STRENGTHENING REFERRALS AND LINKAGES IN SWAZILAND DESIGNER STIMULANT TESTING: A FAST MOVING TARGET LEFT BEHIND IN THE GLOBAL RESPONSE TO HIV ELIMINATING MALARIA IN INDIA NEW GUIDANCE FOR PHYSICIANS FOR ACCURATELY DIAGNOSING C. DIFFICILE INFECTION CLINICIANS GATHER TO ENCOURAGE POINT-OF-CARE TESTING IN LATIN AMERICA DIAGNOSTICS AT DAVOS: A CALL TO DEPLOY POCT TO ADDRESS THE TOLLS OF ANTIMICROBIAL RESISTANCE RSV. IT’S NOT JUST FOR KIDS ANYMORE! IMPROVING TYPE 2 DIABETES AND HYPERTENSION SERVICES IN HONDURAS THE GLOBAL THREAT OF DRUG-RESISTANT TUBERCULOSIS – ARE WE DOING ENOUGH? WORKPLACE POLICIES FOR PRESCRIPTION DRUGS DIAGNOSIS AND MANAGEMENT OF THE DIABETES EPIDEMIC IN THE PACIFIC ISLANDS DIAGNOSTIC ACCESS IN AFRICA: THE EVOLUTION OF HIV POINT-OF-CARE TESTING IN UGANDA THE BENEFITS OF PRE-EMPLOYMENT DRUG TESTING THE EXPANDED ROLE FOR AUSTRALIAN COMMUNITY PHARMACY IN CHRONIC DISEASE MANAGEMENT SHIFTING PARADIGMS IN CONNECTIVITY: HOW KNOWLEDGE MANAGEMENT CAN STRENGTHEN POINT OF CARE PROGRAMS VTE CARDIOMETABOLIC SERVICES HIV LEGIONNAIRE'S DISEASE INFLUENZA (FLU) MALARIA MONONUCLEOSIS MRSA MUMPS PNEUMONIA RSV S. AUREUS STREP A PHARYNGITIS STREPTOCOCCUS PNEUMONIAE SYPHILIS C-REACTIVE PROTEIN DIAGNOSTIC TESTS TUBERCULOSIS OTHER INFECTIOUS DISEASE ALERE I ALERE INFLUENZA A & B TEST ALERE NMP22 ALERE PBP2A ALERE PIMA CD4 ALERE Q ALERE TESTPACK ALERE TOXICOLOGY ALERE TRIAGE CLEARVIEW EPOC NYCOCARD TECHLAB ADDITIONAL BRANDS CLEARVIEW EPOC SD BIOLINE TECHLAB Home S. aureus ALERE™ PBP2A CULTURE COLONY TEST A rapid immunochromatographic qualitative assay for the detection of penicillin binding protein 2a (PBP2a) direct from S. aureus culture isolates as an aid in detecting methicillin-resistant Staphylococcus aureus (MRSA). CONTACT SALES TECHNICAL SUPPORT ALERE PBP2A CULTURE COLONY TEST BENEFITS HELPFUL DOCUMENTS VIDEOS RELATED PRODUCTS BENEFITS RAPID The test yields clear, objective results within 6 minutes including sample preparation. EASY TO USE The test requires no boiling step or centrifuging step. KNOWING NOW MATTERS.™ Alere delivers reliable and actionable information through rapid diagnostic tests, helping to deliver better clinical and economic healthcare outcomes globally. DISCOVER OUR DIAGNOSTIC PRODUCTS HELPFUL DOCUMENTS PRODUCT DOCUMENTS SPECIFICATIONS PRODUCT CODE VIDEOS Learn how to use the Alere™ PBP2a test by watching this product demonstration. RELATED PRODUCTS Alere BinaxNOW® Staphylococcus aureus Test Alere™ PBP2a Culture Colony Test ABOUT PEOPLE & CULTURE CORPORATE RESPONSIBILITY ALERE STORIES NEWS & EVENTS OUR HISTORY ALERE LOCATIONS VIEWPOINTS PRODUCTS & SERVICES CARDIOMETABOLIC INFECTIOUS DISEASE TOXICOLOGY OTHER BROWSE BY BRAND SOLUTIONS INVESTORS ANNUAL MEETINGS & REPORTS SEC FILINGS & FINANCIALS FINANCIAL RELEASES CORPORATE GOVERNANCE PRESENTATIONS & EVENTS CONTACT INFORMATION SUPPORT CONTACT US PRODUCT DOCUMENT SEARCH PRODUCT DEMOS LABORATORY TEST SUPPORT RESOURCES MEDICAL WEBINARS Discover how our innovative diagnostics deliver reliable and actionable information. ALERE-EPOC.COM ALERE-I.COM TESTTARGETTREAT.COM Contact Us Product Document Search Careers ©2010-2017 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. California Transparency in Supply Chains Act | Declaration for California Compliance Law Alere - A Leader in Rapid Point-of-Care Diagnostics.